Why are women predisposed to autoimmune rheumatic diseases?

Arthritis Research and Therapy

Volumn 11, Issue 5, 2009, Pages

  Oliver, Jacqueline E ^a   Silman, Alan J ^b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b Arthritis Research Campaign   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ESTROGEN; ESTRONE; PRASTERONE SULFATE; PROLACTIN; SEX HORMONE;

BREAST FEEDING; CIGARETTE SMOKING; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; ETHNICITY; FEMALE; GENETIC ASSOCIATION; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; KLINEFELTER SYNDROME; LIFESTYLE; MENARCHE; MENOPAUSE; MICROCHIMERISM; MONOSOMY; PREGNANCY; REVIEW; RHEUMATOID ARTHRITIS; RISK FACTOR; SCLERODERMA; SEX DIFFERENCE; SILICONE PROSTHESIS; SYSTEMIC LUPUS ERYTHEMATOSUS; WORK; X CHROMOSOME INACTIVATION; AUTOIMMUNE DISEASE; GENETIC PREDISPOSITION; GENETICS; IMMUNOLOGY; METABOLISM; RHEUMATIC DISEASE;

AUTOIMMUNE DISEASES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GONADAL STEROID HORMONES; HUMANS; PREGNANCY; RHEUMATIC DISEASES; RISK FACTORS; SEX FACTORS;

EID: 75649135323     PISSN: 14786354     EISSN: 14786362     Source Type: Journal    
DOI: 10.1186/ar2825     Document Type: Review

References (85)

1. Fairweather D, Frisancho-Kiss S, Rose NR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol 2008, 173:600-609. 18688037, 10.2353/ajpath.2008.071008, 2527069.
2. Sokka T, Toloza S, Cutolo M, Kautiainen H, Makinen H, Gogus F, Skakic V, Badsha H, Peets T, Baranauskaite A, Geher P, Ujfalussy I, Skopouli FN, Mavrommati M, Alten R, Pohl C, Sibilia J, Stancati A, Salaffi F, Romanowski W, Zarowny-Wierzbinska D, Henrohn D, Bresnihan B, Minnock P, Knudsen LS, Jacobs JW, Calvo-Alen J, Lazovskis J, Pinheiro GD, Karateev D, et al. Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA Study. Arthritis Res Ther 2009, 11:R7. 2688237, 19144159.
3. Wiles N, Symmons DP, Harrison B, Barrett E, Barrett JH, Scott DG, Silman AJ. Estimating the incidence of rheumatoid arthritis: trying to hit a moving target?. Arthritis Rheum 1999, 42:1339-1346. 10403260, 10.1002/1529-0131(199907)42:7<1339::AID-ANR6>3.0.CO;2-Y.
4. Chifflot H, Fautrel B, Sordet C, Chatelus E, Sibilia J. Incidence and prevalence of systemic sclerosis: a systematic literature review. Semin Arthritis Rheum 2008, 37:223-235. 17692364, 10.1016/j.semarthrit.2007.05.003.
5. Steen VD, Oddis CV, Conte CG, Janoski J, Casterline GZ, Medsger TA. Incidence of systemic sclerosis in Allegheny County, Pennsylvania. A twenty-year study of hospital-diagnosed cases, 1963-1982. Arthritis Rheum 1997, 40:441-445. 9082931, 10.1002/art.1780400309.
6. D'Cruz DP, Khamashta MA, Hughes GR. Systemic lupus erythematosus. Lancet 2007, 369:587-596. 17307106, 10.1016/S0140-6736(07)60279-7.
7. Alamanos Y, Voulgari PV, Drosos AA. Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review. Semin Arthritis Rheum 2006, 36:182-188. 17045630, 10.1016/j.semarthrit.2006.08.006.
8. Silman AJ. Rheumatoid arthritis. Epidemiology of the rheumatic diseases 2001, 31-71. Oxford: Oxford University Press, Silman AJ, Hochberg MC, 2.
9. Petri M. Epidemiology of systemic lupus erythematosus. Best Pract Res Clin Rheumatol 2002, 16:847-858. 12473278, 10.1053/berh.2002.0259.
10. Rus V, Hajeer A, Hochberg MC. Systemic lupus erythematosus. Epidemiology of the rheumatic diseases 2001, 123-140. Oxford: Oxford University Press, Silman AJ, Hochberg MC, 2.
11. Silman AJ. Scleroderma. Epidemiology of the rheumatic diseases 2001, 141-162. Oxford: Oxford University Press, Silman AJ, Hochberg MC, 2.
12. Laing TJ, Gillespie BW, Toth MB, Mayes MD, Gallavan RH, Burns CJ, Johanns JR, Cooper BC, Keroack BJ, Wasko MC, Lacey JV, Schottenfeld D. Racial differences in scleroderma among women in Michigan. Arthritis Rheum 1997, 40:734-742. 9125258, 10.1002/art.1780400421.
13. Zandman-Goddard G, Peeva E, Shoenfeld Y. Gender and autoimmunity. Autoimmun Rev 2007, 6:366-372. 17537382, 10.1016/j.autrev.2006.10.001.
14. Cutolo M, Seriolo B, Villaggio B, Pizzorni C, Craviotto C, Sulli A. Androgens and estrogens modulate the immune and inflammatory responses in rheumatoid arthritis. Ann N Y Acad Sci 2002, 966:131-142. 12114267, 10.1111/j.1749-6632.2002.tb04210.x.
15. Lang TJ. Estrogen as an immunomodulator. Clin Immunol 2004, 113:224-230. 15507385, 10.1016/j.clim.2004.05.011.
16. Nilsson BO. Modulation of the inflammatory response by estrogens with focus on the endothelium and its interactions with leukocytes. Inflamm Res 2007, 56:269-273. 17659431, 10.1007/s00011-007-6198-z.
17. Rider V, Foster RT, Evans M, Suenaga R, Abdou NI. Gender differences in autoimmune diseases: estrogen increases calcineurin expression in systemic lupus erythematosus. Clin Immunol Immunopathol 1998, 89:171-180. 9787119, 10.1006/clin.1998.4604.
18. Rider V, Jones SR, Evans M, Abdou NI. Molecular mechanisms involved in the estrogen-dependent regulation of calcineurin in systemic lupus erythematosus T cells. Clin Immunol 2000, 95:124-134. 10779406, 10.1006/clim.2000.4844.
19. Rider V, Abdou NI. Gender differences in autoimmunity: molecular basis for estrogen effects in systemic lupus erythematosus. Int Immunopharmacol 2001, 1:1009-1024. 11407298, 10.1016/S1567-5769(01)00046-7.
20. Orbach H, Shoenfeld Y. Hyperprolactinemia and autoimmune diseases. Autoimmun Rev 2007, 6:537-542. 17854745, 10.1016/j.autrev.2006.10.005.
21. Spector TD, Perry LA, Tubb G, Silman AJ, Huskisson EC. Low free testosterone levels in rheumatoid arthritis. Ann Rheum Dis 1988, 47:65-68. 3345107, 10.1136/ard.47.1.65, 1003446.
22. Heikkila R, Aho K, Heliovaara M, Knekt P, Reunanen A, Aromaa A, Leino A, Palosuo T. Serum androgen-anabolic hormones and the risk of rheumatoid arthritis. Ann Rheum Dis 1998, 57:281-285. 9741311, 10.1136/ard.57.5.281, 1752601.
23. Spector TD, Ollier W, Perry LA, Silman AJ, Thompson PW, Edwards A. Free and serum testosterone levels in 276 males: a comparative study of rheumatoid arthritis, ankylosing spondylitis and healthy controls. Clin Rheumatol 1989, 8:37-41. 2787224, 10.1007/BF02031066.
24. Masi AT. Hormonal and immunologic risk factors for the development of rheumatoid arthritis: an integrative physiopathogenetic perspective. Rheum Dis Clin North Am 2000, 26:775-803. 11084944, 10.1016/S0889-857X(05)70169-1.
25. Masi AT, Aldag JC. Integrated neuroendocrine immune risk factors in relation to rheumatoid arthritis: should rheumatologists now adopt a model of a multiyear, presymptomatic phase?. Scand J Rheumatol 2005, 34:342-352. 16234181, 10.1080/03009740500327735.
26. Tengstrand B, Carlstrom K, Fellander-Tsai L, Hafstrom I. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 2003, 30:2338-2343.
27. McMurray RW, May W. Sex hormones and systemic lupus erythematosus: review and meta-analysis. Arthritis Rheum 2003, 48:2100-2110. 12905462, 10.1002/art.11105.
28. Costenbader KH, Feskanich D, Stampfer MJ, Karlson EW. Reproductive and menopausal factors and risk of systemic lupus erythematosus in women. Arthritis Rheum 2007, 56:1251-1262. 17393454, 10.1002/art.22510.
29. Karlson EW, Mandl LA, Hankinson SE, Grodstein F. Do breast-feeding and other reproductive factors influence future risk of rheumatoid arthritis? Results from the Nurses' Health Study. Arthritis Rheum 2004, 50:3458-3467. 15529351, 10.1002/art.20621.
30. de Man YA, Dolhain RJ, Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum 2008, 59:1241-1248. 18759316, 10.1002/art.24003.
31. Nelson JL, Ostensen M. Pregnancy and rheumatoid arthritis. Rheum Dis Clin North Am 1997, 23:195-212. 9031383, 10.1016/S0889-857X(05)70323-9.
32. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992, 35:152-155. 1734904, 10.1002/art.1780350205.
33. Lambe M, Bjornadal L, Neregard P, Nyren O, Cooper GS. Child-bearing and the risk of scleroderma: a population-based study in Sweden. Am J Epidemiol 2004, 159:162-166. 14718218, 10.1093/aje/kwh027.
34. Brennan P, Silman A. Breast-feeding and the onset of rheumatoid arthritis. Arthritis Rheum 1994, 37:808-813. 8003052, 10.1002/art.1780370605.
35. Brennan P, Ollier B, Worthington J, Hajeer A, Silman A. Are both genetic and reproductive associations with rheumatoid arthritis linked to prolactin?. Lancet 1996, 348:106-109. 8676677, 10.1016/S0140-6736(96)02037-5.
36. Russell AS, Johnston C, Chew C, Maksymowych WP. Evidence for reduced Th1 function in normal pregnancy: a hypothesis for the remission of rheumatoid arthritis. J Rheumatol 1997, 24:1045-1050.
37. Barrett JH, Brennan P, Fiddler M, Silman AJ. Does rheumatoid arthritis remit during pregnancy and relapse postpartum? Results from a nationwide study in the United Kingdom performed prospectively from late pregnancy. Arthritis Rheum 1999, 42:1219-1227. 10366115, 10.1002/1529-0131(199906)42:6<1219::AID-ANR19>3.0.CO;2-G.
38. Barrett JH, Brennan P, Fiddler M, Silman A. Breast-feeding and postpartum relapse in women with rheumatoid and inflammatory arthritis. Arthritis Rheum 2000, 43:1010-1015. 10817553, 10.1002/1529-0131(200005)43:5<1010::AID-ANR8>3.0.CO;2-O.
39. Chuang E, Molitch ME. Prolactin and autoimmune diseases in humans. Acta Biomed 2007, 78(Suppl 1):255-261.
40. Pikwer M, Bergstrom U, Nilsson JA, Jacobsson L, Berglund G, Turesson C. Breast-feeding, but not oral contraceptives, is associated with a reduced risk of rheumatoid arthritis. Ann Rheum Dis 2009, 68:526-530. 18477739, 10.1136/ard.2007.084707.
41. Cooper GS, Dooley MA, Treadwell EL, St Clair EW, Gilkeson GS. Hormonal and reproductive risk factors for development of systemic lupus erythematosus - results of a population-based, case-control study. Arthritis Rheum 2002, 46:1830-1839. 12124867, 10.1002/art.10365.
42. Pisa FE, Bovenzi M, Romeo L, Tonello A, Biasi D, Bambara LM, Betta A, Barbone F. Reproductive factors and the risk of scleroderma: an Italian case-control study. Arthritis Rheum 2002, 46:451-456. 11840448, 10.1002/art.10178.
43. Artlett CM, Rasheed M, Russo-Stieglitz KE, Sawaya HH, Jimenez SA. Influence of prior pregnancies on disease course and cause of death in systemic sclerosis. Ann Rheum Dis 2002, 61:346-350. 11874839, 10.1136/ard.61.4.346, 1754050.
44. Hannaford PC, Kay CR, Hirsch S. Oral contraceptives and rheumatoid arthritis: new data from the Royal College of General Practitioners' oral contraception study. Ann Rheum Dis 1990, 49:744-746. 2241261, 10.1136/ard.49.10.744, 1004223.
45. Oliver JE, Silman AJ. Risk factors for the development of rheumatoid arthritis. Scand J Rheumatol 2006, 35:169-174. 16766362, 10.1080/03009740600718080.
46. Doran MF, Crowson CS, O'Fallon WM, Gabriel SE. The effect of oral contraceptives and estrogen replacement therapy on the risk of rheumatoid arthritis: a population based study. J Rheumatol 2004, 31:207-213.
47. Walitt B, Pettinger M, Weinstein A, Katz J, Torner J, Wasko MC, Howard BV. Effects of postmenopausal hormone therapy on rheumatoid arthritis: the women's health initiative randomized controlled trials. Arthritis Rheum 2008, 59:302-310. 18311749, 10.1002/art.23325, 2661110.
48. Garcia Rodriguez LA, Tolosa LB, Ruigomez A, Johansson S, Wallander MA. Rheumatoid arthritis in UK primary care: incidence and prior morbidity. Scand J Rheumatol 2009, 38:173-177. 19117247, 10.1080/03009740802448825.
49. Santos-Ocampo AS. New onset systemic lupus erythematosus in a transgender man: possible role of feminizing sex hormones. J Clin Rheumatol 2007, 13:29-30. 17278946, 10.1097/01.rhu.0000256169.05087.ad.
50. Yurino H, Ishikawa S, Sato T, Akadegawa K, Ito T, Ueha S, Inadera H, Matsushima K. Endocrine disruptors (environmental estrogens) enhance autoantibody production by B1 cells. Toxicol Sci 2004, 81:139-147. 15166399, 10.1093/toxsci/kfh179.
51. Petri M, Kim MY, Kalunian KC, Grossman J, Hahn BH, Sammaritano LR, Lockshin M, Merrill JT, Belmont HM, Askanase AD, McCune WJ, Hearth-Holmes M, Dooley MA, Von FJ, Friedman A, Tan M, Davis J, Cronin M, Diamond B, Mackay M, Sigler L, Fillius M, Rupel A, Licciardi F, Buyon JP. Combined oral contraceptives in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2550-2558. 16354891, 10.1056/NEJMoa051135.
52. Sanchez-Guerrero J, Uribe AG, Jimenez-Santana L, Mestanza-Peralta M, Lara-Reyes P, Seuc AH, Cravioto MD. A trial of contraceptive methods in women with systemic lupus erythematosus. N Engl J Med 2005, 353:2539-2549. 16354890, 10.1056/NEJMoa050817.
53. Wellcome Trust Case Control Consortium Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature 2007, 447:661-678. 17554300, 10.1038/nature05911, 2719288, Wellcome Trust Case Control Consortium.
54. Lleo A, Battezzati PM, Selmi C, Gershwin ME, Podda M. Is autoimmunity a matter of sex?. Autoimmun Rev 2008, 7:626-630. 18603021, 10.1016/j.autrev.2008.06.009.
55. Ozbalkan Z, Bagislar S, Kiraz S, Akyerli CB, Ozer HT, Yavuz S, Birlik AM, Calguneri M, Ozcelik T. Skewed X chromosome inactivation in blood cells of women with scleroderma. Arthritis Rheum 2005, 52:1564-1570. 15880831, 10.1002/art.21026.
56. Uz E, Loubiere LS, Gadi VK, Ozbalkan Z, Stewart J, Nelson JL, Ozcelik T. Skewed X-chromosome inactivation in scleroderma. Clin Rev Allergy Immunol 2008, 34:352-355. 18157513, 10.1007/s12016-007-8044-z, 2716291.
57. Invernizzi P, Miozzo M, Selmi C, Persani L, Battezzati PM, Zuin M, Lucchi S, Meroni PL, Marasini B, Zeni S, Watnik M, Grati FR, Simoni G, Gershwin ME, Podda M. X chromosome monosomy: a common mechanism for autoimmune diseases. J Immunol 2005, 175:575-578.
58. Invernizzi P, Miozzo M, Oertelt-Prigione S, Meroni PL, Persani L, Selmi C, Battezzati PM, Zuin M, Lucchi S, Marasini B, Zeni S, Watnik M, Tabano S, Maitz S, Pasini S, Gershwin ME, Podda M. X monosomy in female systemic lupus erythematosus. Ann N Y Acad Sci 2007, 1110:84-91. 17911423, 10.1196/annals.1423.010.
59. Scofield RH, Bruner GR, Namjou B, Kimberly RP, Ramsey-Goldman R, Petri M, Reveille JD, Alarcon GS, Vila LM, Reid J, Harris B, Li S, Kelly JA, Harley JB. Klinefelter's syndrome (47,XXY) in male systemic lupus erythematosus patients: support for the notion of a gene-dose effect from the X chromosome. Arthritis Rheum 2008, 58:2511-2517. 18668569, 10.1002/art.23701.
60. Harney S, Newton J, Milicic A, Brown MA, Wordsworth BP. Non-inherited maternal HLA alleles are associated with rheumatoid arthritis. Rheumatology (Oxford) 2003, 42:171-174. 12509632, 10.1093/rheumatology/keg059.
61. Horst-Bruinsma IE, Hazes JM, Schreuder GM, Radstake TR, Barrera P, Putte LB, Mustamu D, van SD, Breedveld FC, de Vries RR. Influence of non-inherited maternal HLA-DR antigens on susceptibility to rheumatoid arthritis. Ann Rheum Dis 1998, 57:672-675. 9924209, 10.1136/ard.57.11.672, 1752500.
62. Barrera P, Balsa A, Alves H, Westhovens R, Maenaut K, Cornelis F, Fritz P, Bardin T, de Almeida G, Lopes-Vaz A, Pascual SD, de la Concha EG, Radstake TR, Putte LB, Migliorini P, Prud'homme JF, Charron D, Spyropoulou M, Mendes A, Spaepen M, Martinez M, Lepage V, Stravopoulos C. Noninherited maternal antigens do not play a role in rheumatoid arthritis susceptibility in Europe. European Consortium on Rheumatoid Arthritis Families. Arthritis Rheum 2000, 43:758-764. 10765920, 10.1002/1529-0131(200004)43:4<758::AID-ANR6>3.0.CO;2-6.
63. Guthrie KA, Tishkevich NR, Nelson JL. Non-inherited maternal human leukocyte antigen alleles in susceptibility to familial rheumatoid arthritis. Ann Rheum Dis 2009, 68:107-109. 18684745, 10.1136/ard.2008.092312, 2760537.
64. Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, Bean MA, Ober C, Bianchi DW. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet 1998, 351:559-562. 9492775, 10.1016/S0140-6736(97)08357-8.
65. Evans PC, Lambert N, Maloney S, Furst DE, Moore JM, Nelson JL. Long-term fetal microchimerism in peripheral blood mononuclear cell subsets in healthy women and women with scleroderma. Blood 1999, 93:2033-2037.
66. Johnson KL, McAlindon TE, Mulcahy E, Bianchi DW. Microchimerism in a female patient with systemic lupus erythematosus. Arthritis Rheum 2001, 44:2107-2111. 11592373, 10.1002/1529-0131(200109)44:9<2107::AID-ART361>3.0.CO;2-9.
67. Mosca M, Curcio M, Lapi S, Valentini G, D'Angelo S, Rizzo G, Bombardieri S. Correlations of Y chromosome microchimerism with disease activity in patients with SLE: analysis of preliminary data. Ann Rheum Dis 2003, 62:651-654. 12810428, 10.1136/ard.62.7.651, 1754588.
68. Lambert NC, Pang JM, Yan Z, Erickson TD, Stevens AM, Furst DE, Nelson JL. Male microchimerism in women with systemic sclerosis and healthy women who have never given birth to a son. Ann Rheum Dis 2005, 64:845-848. 15550532, 10.1136/ard.2004.029314, 1755528.
69. Rak JM, Maestroni L, Balandraud N, Guis S, Boudinet H, Guzian MC, Yan Z, Azzouz D, Auger I, Roudier C, Martin M, Didelot R, Roudier J, Lambert NC. Transfer of the shared epitope through microchimerism in women with rheumatoid arthritis. Arthritis Rheum 2009, 60:73-80. 19117368, 10.1002/art.24224.
70. Finckh A, Cooper GS, Chibnik LB, Costenbader KH, Watts J, Pankey H, Fraser PA, Karlson EW. Occupational silica and solvent exposures and risk of systemic lupus erythematosus in urban women. Arthritis Rheum 2006, 54:3648-3654. 17075811, 10.1002/art.22210.
71. Sanchez-Guerrero J, Karlson EW, Colditz GA, Hunter DJ, Speizer FE, Liang MH. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1996, 39:657-662. 8630117, 10.1002/art.1780390418.
72. Wang J, Kay AB, Fletcher J, Formica MK, McAlindon TE. Is lipstick associated with the development of systemic lupus erythematosus (SLE)?. Clin Rheumatol 2008, 27:1183-1187. 18523821, 10.1007/s10067-008-0937-6.
73. Spiera H, Kerr LD. Scleroderma following silicone implantation: a cumulative experience of 11 cases. J Rheumatol 1993, 20:958-961.
74. Strom BL, Reidenberg MM, Freundlich B, Schinnar R. Breast silicone implants and risk of systemic lupus erythematosus. J Clin Epidemiol 1994, 47:1211-1214. 7722556, 10.1016/0895-4356(94)90109-0.
75. Lipworth L, Tarone RE, McLaughlin JK. Silicone breast implants and connective tissue disease: an updated review of the epidemiologic evidence. Ann Plast Surg 2004, 52:598-601. 15166995, 10.1097/01.sap.0000128087.51384.f9.
76. Criswell LA, Merlino LA, Cerhan JR, Mikuls TR, Mudano AS, Burma M, Folsom AR, Saag KG. Cigarette smoking and the risk of rheumatoid arthritis among postmenopausal women: results from the Iowa Women's Health Study. Am J Med 2002, 112:465-471. 11959057, 10.1016/S0002-9343(02)01051-3.
77. Krishnan E, Sokka T, Hannonen P. Smoking-gender interaction and risk for rheumatoid arthritis. Arthritis Res Ther 2003, 5:R158-R162. 12723987, 10.1186/ar750, 165046.
78. Criswell LA, Saag KG, Mikuls TR, Cerhan JR, Merlino LA, Lum RF, Pfeiffer KA, Woehl B, Seldin MF. Smoking interacts with genetic risk factors in the development of rheumatoid arthritis among older Caucasian women. Ann Rheum Dis 2006, 65:1163-1167. 16887863, 10.1136/ard.2005.049676, 1798304.
79. Jawaheer D, Lum RF, Gregersen PK, Criswell LA. Influence of male sex on disease phenotype in familial rheumatoid arthritis. Arthritis Rheum 2006, 54:3087-3094. 17009227, 10.1002/art.22120.
80. Lockshin MD. Biology of the sex and age distribution of systemic lupus erythematosus. Arthritis Rheum 2007, 57:608-611. 17471529, 10.1002/art.22676.
81. Selmi C. The X in sex: how autoimmune diseases revolve around sex chromosomes. Best Pract Res Clin Rheumatol 2008, 22:913-922. 19028371, 10.1016/j.berh.2008.09.002.
82. Arber S, McKinlay J, Adams A, Marceau L, Link C, O'Donnell A. Patient characteristics and inequalities in doctors' diagnostic and management strategies relating to CHD: a video-simulation experiment. Soc Sci Med 2006, 62:103-115. 16002197, 10.1016/j.socscimed.2005.05.028.
83. Alamanos Y, Drosos AA. Epidemiology of adult rheumatoid arthritis. Autoimmun Rev 2005, 4:130-136. 15823498, 10.1016/j.autrev.2004.09.002.
84. Sanchez-Guerrero J, Karlson EW, Liang MH, Hunter DJ, Speizer FE, Colditz GA. Past use of oral contraceptives and the risk of developing systemic lupus erythematosus. Arthritis Rheum 1997, 40:804-808. 9153539, 10.1002/art.1780400505.
85. Meier CR, Sturkenboom MCJM, Cohen AS, Jick H. Post-menopausal estrogen replacement therapy and the risk of developing systemic lupus erythematosus or discoid lupus. J Rheumatol 1998, 25:1515-1519.